Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02035696 · ClinicalTrials.gov registry record · Phase 1
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
A Phase 1 study, sponsored by Seqirus.
- Completed
- Registry status
- Phase 1
- Development phase
- 671
- Enrollment target
NCT02035696: Completed Phase 1 study, sponsored by Seqirus.
NCT02035696 is a Phase 1 study that has completed, run by Seqirus. The registered enrollment target is 671 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1018% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02035696, a Phase 1 study, has completed, sponsored by Seqirus.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 671 participants
- Enrollment target
Study Summary
To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age
Primary Outcome
Immunogenicity was assessed in terms of ratios of GMTs in subjects (6 to \<48 months old), measured by hemagglutination inhibition (HI) assay, day 1 to day 50 after vaccination with two doses of either TIVc or TIVe vaccine
Interventions
- BIOLOGICAL Trivalent influenza vaccine (TIVc)
- BIOLOGICAL Trivalent influenza vaccine-licensed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 671 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
What the finished NCT02035696 record still lists
NCT02035696 is an interventional study that assigns participants to a tested intervention. The registered 671 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1018% higher).
The record links to 0 conditions, and to 2 interventions - of which Trivalent influenza vaccine (TIVc) is the first listed.
NCT02035696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02035696 about?
NCT02035696 is a clinical study titled "Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old". To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age
What is the current status of trial NCT02035696?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 671 participants. The study started on 2013-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02035696?
The interventions under investigation include: Trivalent influenza vaccine (TIVc) (BIOLOGICAL), Trivalent influenza vaccine-licensed (BIOLOGICAL).
Who is sponsoring clinical trial NCT02035696?
This trial is sponsored by Seqirus, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02035696's enrollment target sits among peer trials
671 22nd of 2000 higher than 1,979 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia